A pioneering surgical robot purpose-built for operating on children has expanded into Japan, deployed last month at Nagoya University Hospital.

The Senhance System by North Carolina-based Asensus Surgical has become the globe’s first pediatric robot-assisted platform cleared for a variety of minimally-invasive procedures. With tabletop machines typically designed for adults, Senhance breaks new ground with scaled instrumentation and tailored features protecting young patients.

That includes 3mm tools - the smallest available for laparoscopic surgery - to leave behind less scarring while accessing tiny, complex anatomy. Advanced augmented intelligence also guides surgeons with enhanced visibility, control and haptic feedback for delicate tissue manipulation.

Senhance builds on two decades of innovation from Asensus, which now counts over 13,000 procedures leveraging its technology worldwide. Global regulators have cleared the system across general, gynecological and now pediatric surgeries after initially debuting in the United States in 2017.

The latest Nagoya University Hospital installation specifically targets benefits for children, from tiny premature infants to teenagers. It becomes Asensus’ fourth Senhance placement just within Japan as the country emerges as a leading clinical proving ground.

“The reusable instruments offer distinct advantages tailored to pediatric surgery,” said Dr. Hiroo Uchida, who heads the hospital’s pediatric surgery department. He added Senhance provides superior camera control, safety and value for minimally invasive operations.

Asensus also continues advancing its next-gen successor, Luna, which it believes could one day drive wider transformation in surgical robotics. For now, early capabilities like Senhance offer special promise of improving care and recovery for children through patient-matched technology.

"Designed with smaller patients in mind, the system represents a significant step forward in pediatric surgery,” said Asensus president Anthony Fernando.